In the study, artemisinin was shown to significantly decrease TGF-β mRNA levels and populations of MDSCs and Treg cells within the tumor, while increasing TNF-α mRNA levels, CD4+ interferon gamma-expressed (IFN-γ+) T cells, and cytotoxic T lymphocytes [189]. Here, TGFB1 is linked to neoplasm.